ABBV (ABBVIE INC.)
Insider Trading Activity
Every open-market purchase and sale reported by ABBV officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | MIXED | — | — |
| 2026-07-02 | Susan E Quaggin | Director | A | — | — |
| 2026-07-02 | EDWARD J RAPP | Director | A | — | — |
| 2026-05-12 | ROXANNE S AUSTIN | Director | A | — | — |
| 2026-05-12 | WILLIAM H.L. BURNSIDE | Director | A | — | — |
| 2026-05-12 | Jennifer L. Davis | Director | A | — | — |
| 2026-05-12 | THOMAS C FREYMAN | Director | A | — | — |
| 2026-05-12 | Brett J Hart | Director | A | — | — |
| 2026-05-12 | MELODY B MEYER | Director | A | — | — |
| 2026-05-12 | Susan E Quaggin | Director | A | — | — |
| 2026-05-12 | EDWARD J RAPP | Director | A | — | — |
| 2026-05-12 | Rebecca B Roberts | Director | A | — | — |
| 2026-05-12 | FREDERICK H WADDELL | Director | A | — | — |
| 2026-05-12 | THOMAS J FALK | Director | A | — | — |
| 2026-04-02 | Robert J Alpern | Director | A | — | — |
| 2026-04-02 | EDWARD J RAPP | Director | A | — | — |
| 2026-04-02 | Susan E Quaggin | Director | A | — | — |
| 2026-03-11 | David Ryan Purdue | SVP, Controller | F | — | — |
| 2026-03-06 | Demetris D Crum | EVP, CHIEF HR OFFICER | F | — | — |
| 2026-03-06 | David Ryan Purdue | SVP, Controller | Sell | — | — |
| 2026-03-03 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | F | — | — |
| 2026-03-03 | AZITA SALEKI-GERHARDT | EVP, CHIEF OPERATIONS OFFICER | F | — | — |
| 2026-03-03 | David Ryan Purdue | SVP, Controller | F | — | — |
| 2026-03-03 | Scott T Reents | EVP, CHIEF FINANCIAL OFFICER | F | — | — |
| 2026-03-03 | Perry C Siatis | EVP, GC AND SECRETARY | MIXED | — | — |
| 2026-03-03 | Jeffrey Ryan Stewart | EVP, CHIEF COMMERCIAL OFFICER | F | — | — |
| 2026-03-03 | Robert A. Michael | CHAIRMAN OF THE BOARD AND CEO | F | — | — |
| 2026-03-03 | Roopal Thakkar | EVP, R&D and CSO | F | — | — |
| 2026-02-27 | Perry C Siatis | EVP, GC AND SECRETARY | MIXED | — | — |
| 2026-02-20 | Robert A. Michael | CHIEF EXECUTIVE OFFICER | A | — | — |
| 2026-02-20 | Scott T Reents | EVP, CHIEF FINANCIAL OFFICER | A | — | — |
| 2026-02-20 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | A | — | — |
| 2026-02-20 | Demetris D Crum | EVP, CHIEF HR OFFICER | A | — | — |
| 2026-02-20 | AZITA SALEKI-GERHARDT | EVP, CHIEF OPERATIONS OFFICER | A | — | — |
| 2026-02-20 | Perry C Siatis | EVP, GC AND SECRETARY | A | — | — |
| 2026-02-20 | Jeffrey Ryan Stewart | EVP, CHIEF COMMERCIAL OFFICER | A | — | — |
| 2026-02-20 | David Ryan Purdue | SVP, Controller | A | — | — |
| 2026-02-20 | Roopal Thakkar | EVP, R&D and CSO | A | — | — |
| 2026-01-05 | EDWARD J RAPP | Director | A | — | — |
| 2026-01-05 | Susan E Quaggin | Director | A | — | — |
| 2026-01-05 | Robert J Alpern | Director | A | — | — |
| 2025-10-02 | EDWARD J RAPP | Director | A | — | — |
| 2025-10-02 | Robert J Alpern | Director | A | — | — |
| 2025-10-02 | Susan E Quaggin | Director | A | — | — |
| 2025-08-14 | AZITA SALEKI-GERHARDT | EVP, CHIEF OPERATIONS OFFICER | MIXED | — | — |
| 2025-08-07 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sell | — | — |
| 2025-07-02 | Susan E Quaggin | Director | A | — | — |
| 2025-07-02 | EDWARD J RAPP | Director | A | — | — |
| 2025-07-02 | Robert J Alpern | Director | A | — | — |
| 2025-05-13 | EDWARD J RAPP | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | EXECUTIVE CHAIRMAN OF BOARD | 392,379 | — |
| — | Vice Chairman | 248,002 | — |
| — | EVP, CHIEF OPERATIONS OFFICER | 200,500 | — |
| — | CHAIRMAN OF THE BOARD AND CEO | 178,737 | — |
| — | EVP, Finance & Administration | 170,053 | — |
| — | Vice Chairman | 155,341 | — |
| — | Vice Chairman | 152,103 | — |
| — | Director | 129,810 | — |
| — | SVP, Chief Scientific Officer | 113,793 | — |
| — | SVP, CSO, GLOBAL RESEARCH | 107,267 | — |
| — | EVP, CHIEF BUS/STRAT OFFICER | 107,140 | — |
| — | EVP, CHIEF COMMERCIAL OFFICER | 84,509 | — |
| — | VP, Controller | 67,923 | — |
| — | Director | 56,352 | — |
| — | EVP, R&D and CSO | 55,374 | — |
| — | Director | 51,914 | — |
| — | EVP, Chief Strategy Officer | 45,261 | — |
| — | Director | 39,576 | — |
| — | EVP, CHIEF FINANCIAL OFFICER | 38,777 | — |
| — | Director | 35,646 | — |
| — | SVP, US COMMERCIAL OPERATIONS | 35,330 | — |
| — | VP, CONTROLLER | 33,402 | — |
| — | Director | 30,076 | — |
| — | Director | 28,076 | — |
| — | SVP & PRES GLOBAL ALLERG AESTH | 28,024 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ABBV quote page; the site-wide leaderboard is on the insider transactions hub.